Search results
Joseph A. Sparano, MD, FACP is the Ezra M. Greenspan, M.D. Professor in Clinical Cancer Therapeutics, Chief of the Division of Hematology Oncology, and Deputy Director of the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai in New York.
20 Mac 2024 · Joseph A. Sparano, MD, FACP, an internationally-recognized expert in the management of breast cancer and HIV-associated malignancies, is Chief of the Division of Hematology and Medical Oncology for the Mount Sinai Health System and Deputy Director of The Tisch Cancer Institute (TCI).
Research led by Joseph Sparano, M.D., may help oncologists refine their use of chemotherapy and hormone therapy for women with early-stage disease. Dr. Dr. Sparano is vice chairman of medical oncology at Montefiore Einstein Center for Cancer Care and associate director of clinical research at the NCI-designated Albert Einstein Cancer Center.
Joseph Sparano, MD. Professor of Medicine (Hematology and Medical Oncology) Chief, Division of Hematology and Medical Oncology. The Division of Hematology and Medical Oncology in The Tisch Cancer Institute represents one of the largest clinical and research divisions at Icahn School of Medicine.
14 Nov 2019 · As a child growing up in the Bronx, New York, Joseph Sparano, MD, watched as his grandmother battled locally advanced breast cancer. She lived with his family at the time, and those early memories of the pain she endured drove his decision to pursue medicine and become a cancer specialist.
Dr. Sparano is a professor and researcher at Mount Sinai, leading efforts to identify biomarkers and improve treatment outcomes for breast cancer patients. He oversees ongoing studies in invasive lobular cancer, late relapse, and personalized medicine.
Joseph A Sparano. Purpose Endocrine-based therapy is the initial primary treatment option for hormone receptor–positive and human epidermal growth factor receptor 2-negative (HR+/HER2−)...
